Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts

Medical Care

Volumn 52, Issue 10, 2014, Pages e65-e73

  Hassett, Michael J ^a,b   Ritzwoller, Debra P ^c   Taback, Nathan ^d   Carroll, Nikki ^c   Cronin, Angel M ^a   Ting, Gladys V ^a   Schrag, Deb ^a,b   Warren, Joan L ^e   Hornbrook, Mark C ^f   Weeks, Jane C ^a,b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c KAISER PERMANENTE   (United States)

^d UNIVERSITY OF TORONTO   (Canada)

^e NATIONAL CANCER INSTITUTE   (United States)

^f CENTER FOR HEALTH RESEARCH   (United States)

Author keywords

Administrative data; Applied methods; Cancer; Recurrence

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL INDICATOR; COLORECTAL CANCER; FEMALE; GOLD STANDARD; HEALTH MAINTENANCE ORGANIZATION; HUMAN; LOCAL THERAPY; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; METASTASIS; PREDICTIVE VALUE; PROSTATE CANCER; SENSITIVITY AND SPECIFICITY; ALGORITHM; BREAST TUMOR; CLASSIFICATION; CODING; COHORT ANALYSIS; COLORECTAL TUMOR; FORECASTING; HEALTH STATUS INDICATOR; LUNG TUMOR; MIDDLE AGED; MORTALITY; PATHOLOGY; PROSTATE TUMOR; REPRODUCIBILITY; STATISTICS; TUMOR RECURRENCE; UNITED STATES; VALIDATION STUDY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALGORITHMS; BREAST NEOPLASMS; CLINICAL CODING; COHORT STUDIES; COLORECTAL NEOPLASMS; FEMALE; FORECASTING; HEALTH MAINTENANCE ORGANIZATIONS; HEALTH STATUS INDICATORS; HUMANS; LUNG NEOPLASMS; MALE; MEDICARE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROSTATIC NEOPLASMS; REPRODUCIBILITY OF RESULTS; UNITED STATES;

EID: 84908556887     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0b013e318277eb6f     Document Type: Article

References (23)

1. Kochanek K, Xu J, Murphy SL, et al. Deaths: preliminary data for 2009. National Vital Statistics Report. 2011; 59: 1-51. Available at: http://www.cdc.gov/nchs/data/nvsr/nvsr59/nvsr59-04.pdf. Accessed March 16, 2011.
2. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2009 (Vintage 2009 Populations). Bethesda, MD: National Cancer Institute. Available at: http://seer.cancer.gov/csr/1975-2009-pops09/; 2012. Accessed on August 27, 2012.
3. Jacobson M, Earle CC, Newhouse JP. Geographic variation in physicians' responses to a reimbursement change. N Engl J Med. 2011; 365: 2049-2052.
4. Hu CY, Delclos GL, Chan W, et al. Assessing the initiation and completion of adjuvant chemotherapy in a large nationwide and population-based cohort of elderly patients with stage-III colon cancer. Med Oncol. 2011; 28: 1062-1074.
5. Gray SW, Landrum MB, Lamont EB, et al. Improved outcomes associated with higher surgery rates for older patients with early stage nonsmall cell lung cancer. Cancer. 2012; 118: 1404-1411.
6. Chavez-MacGregor M, Zhao H, Fang S, et al. Complications associated with erythropoietin-stimulating agents in patients with metastatic breast cancer: a Surveillance, Epidemiology, and End Results-Medicare study. Cancer. 2011; 117: 3641-3649.
7. Doubeni CA, Field TS, Buist DS, et al. Racial differences in tumor stage and survival for colorectal cancer in an insured population. Cancer. 2007; 109: 612-620.
8. Field TS, Bosco JL, Prout MN, et al. Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer. J Am Coll Surg. 2011; 213: 757-765.
9. McCahill LE, Single RM, Aiello Bowles EJ, et al. Variability in reexcision following breast conservation surgery. JAMA. 2012; 307: 467-475.
10. Stokes ME, Thompson D, Montoya EL, et al. Ten-year survival and cost following breast cancer recurrence: estimates from SEER-medicare data. Value Health. 2008; 11: 213-220.
11. Schootman M, Jeffe DB, Gillanders WE, et al. Racial disparities in the development of breast cancer metastases among older women: a multilevel study. Cancer. 2009; 115: 731-740.
12. Gooden KM, Howard DL, Carpenter WR, et al. The effect of hospital and surgeon volume on racial differences in recurrence-free survival after radical prostatectomy. Med Care. 2008; 46: 1170-1176.
13. Cummings KC III, Xu F, Cummings LC, et al. A comparison of epidural analgesia and traditional pain management effects on survival and cancer recurrence after colectomy: a population-based study. Anesthesiology. 2012; 116: 797-806.
14. Earle CC, Nattinger AB, Potosky AL, et al. Identifying cancer relapse using SEER-Medicare data. Med Care. 2002; 40(suppl): 75-81.
15. Lamont EB, Herndon JE II, Weeks JC, et al. Measuring disease-free survival and cancer relapse using Medicare claims from CALGB breast cancer trial participants (companion to 9344).[erratum appears in J Natl Cancer Inst. 2006; 98(21): 1584]. J Natl Cancer Inst. 2006; 98: 1335-1338.
16. Ayanian JZ, Chrischilles EA, Fletcher RH, et al. Understanding cancer treatment and outcomes: the Cancer Care Outcomes Research and Surveillance Consortium. [see comment][erratum appears in J Clin Oncol. 2004; 22(24): 5026]. J Clin Oncol. 2004; 22: 2992-2996.
17. Hornbrook MC, Hart G, Ellis JL, et al. Building a virtual cancer research organization. J Natl Cancer Inst Monogr. 2005; 35: 12-25.
18. Ritzwoller DP, Carroll N, Delate T, et al. Validation of electronic data on chemotherapy and hormone therapy use in HMOs. Med Care. 2013; 51: e67-e73.
19. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987; 40: 373-383.
20. Katz JN, Chang LC, Sangha O, et al. Can comorbidity be measured by questionnaire rather than medical record review? Med Care. 1996; 34: 73-84.
21. McClish D, Penberthy L, Pugh A. Using Medicare claims to identify second primary cancers and recurrences in order to supplement a cancer registry. J Clin Epidemiol. 2003; 56: 760-767.
22. Chuback J, Yu O, Pocobelli G, et al. Administrative data algorithms to identify second breast cancer events following early-stage invasive breast cancer. J Natl Cancer Inst. 2012; 104: 931-940.
23. Kimmick GG, Camacho F, Hwang W, et al. Adjuvant radiation and outcomes after breast conserving surgery in publicly insured patients. J Geriatr Oncol. 2012; 3: 138-146.